ArticleFrontiers in immunology2018

Tumor-Derived Microvesicles Enhance Cross-Processing Ability of Clinical Grade Dendritic Cells.

Marco Dionisi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.